bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.04.14.648682

Vector Competence of Temperate and Tropical Mosquito Species for Babanki virus

Abstract

Babanki virus (BBKV), an alphavirus belonging to the Western Equine encephalitis complex, was isolated from Mansonia africana mosquitoes in 1969 but is not characterized yet. Transmitted to humans and animals through the bite of an infectious female arthropod, it is associated with febrile illness, rash, and arthritis similarly to Sindbis virus to which it is related. No specific treatment or vaccine is available. To investigate any risk of propagation, our study investigated the vector competence of several mosquito species towards BBKV. For this purpose, laboratory mosquito colonies from metropolitan France: Culex pipiens (Paris), Aedes albopictus (Nice) as well as tropical area: Aedes albopictus (Saint-Benoit, La Reunion) and Culex quinquefasciatus (Slab strain), Aedes aegypti (PAEA) were exposed to an artificial blood meal infected with BBKV molecular clone. Midguts, legs, salivary glands and saliva were collected from individual mosquitoes of different strains or species at various time points to assess the infection status, viral replication, and infectiousness. At 7 days post viral exposure, infection rates exceeded 70% in Aedes and 40% in Culex species. They remain above 50% except for Culex quinquefasciatus which decreases to 35% at 14 days post viral exposure. Using genome and protein detection, the dissemination rates are above 50% except for Aedes albopictus (Nice) at 7 days post viral exposure. Infection assays using VeroE6 cells indicated that BBKV replicative viral particles were found in the saliva of the different populations tested. Our data demonstrate that different mosquitoes species from both temperate and tropical areas are competent to transmit BBKV suggesting an emergence risk that could trigger an outbreak in humans. Author SummaryBabanki virus (BBKV) is a non-characterized arbovirus identified in 1969 in Cameroon. BBKV is closely related to Sindbis virus which causes symptoms like febrile illness, rash, and arthritis in humans and animals. Both are alphaviruses within the Western Equine Encephalitis complex. BBKV is identified only in the African continent so far. Despite its potential to cause disease, no effective treatments are available. This study investigates the vector competence of various mosquito species from temperate and tropical regions, to transmit BBKV. After mosquitoes were fed an infectious blood meal, various organs were collected at different time points to assess the infection status, viral replication, and infectiousness. The results showed that BBKV infection occurred in all tested mosquito species and persisted over time, with viral particles detected in mosquito or that can potentially be transmitted to vertebrate hosts via mosquito saliva. These findings highlight the broad vector competence of mosquitoes from diverse climatic regions for BBKV, indicating its potential risk for emergence and outbreaks in different regions of the world. The study emphasizes the need for enhanced surveillance and preventive measures to mitigate the potential threat posed by this emerging virus.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ban, M., Geolier, V., Ferquel, E., Faye, M., Diagne, M. M., Ndiaye, E. H., Fall, G., Diallo, M., Lavillette, D., Choumet, V.. 2025-04-14. Vector Competence of Temperate and Tropical Mosquito Species for Babanki virus. https://doi.org/10.1101/2025.04.14.648682

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Preclinical Development of Enterobacter ludwigii LS57, a Human-Derived Swarming Strain, as a Live Biotherapeutic Product for Inflammatory Bowel Disease

Inflammatory Bowel Disease (IBD) remains an area of major unmet need, and the undefined composition and manufacturing burden of fecal microbiota transplantation have motivated a shift toward single-strain Live Biotherapeutic Products (LBPs). Swarming bacteria are enriched in the stressed gut and limit mucosal damage, but no human-derived swarming strain has been developed as an LBP. We therefore report the complete preclinical development of Enterobacter ludwigii LS57, a swarming strain isolated from human feces. Chemistry, Manufacturing and Controls (CMC) covered a three-tier cell bank, 30 L fed-batch fermentation and a colon-targeted enteric-coated capsule, enabling consistent pilot-scale production. No treatment-related findings emerged in safety pharmacology (Sprague-Dawley rats) or in single-dose and Good Laboratory Practice (GLP)-compliant 1-week repeat-dose toxicity studies (Sprague-Dawley rats and Beagle dogs). LS57 was identified as E. ludwigii by 16S rRNA and whole-genome sequencing and produced metabolites with reported anti-inflammatory activity in culture. In Dextran Sulfate Sodium (DSS)-induced colitis, LS57 reduced weight loss, preserved colon length, lowered colonic pro-inflammatory cytokines and remodeled the gut microbiota. It also attenuated Trinitrobenzene Sulfonic Acid (TNBS)-induced colitis and enhanced the effect of ciclosporin A. In vitro, LS57 was non-hemolytic, non-cytotoxic, and acid-labile, formed no biofilm, and its resistance to aminopenicillins, cephamycins and imipenem was not transferable by conjugation. In vivo, LS57 colonized the inflamed colon without translocation in wild-type and interleukin-10-deficient mice, and experimental bacteremia was treatable with gentamicin or levofloxacin. LS57 combines efficacy across two mechanistically distinct colitis models with a safety package that addresses the principal regulatory concerns for LBPs, and a scalable manufacturing process, compatible with current good manufacturing practice, in which enteric coating overcomes the strain's poor gastric survival. These data support clinical development of LS57 in IBD.

microbiology↗

Characterization of Lactobacillus rhamnosus-Derived Extracellular Vesicles and Their Cellular Cytoprotective Effects Against Trimethylamine-Induced Oxidative Stress in Caco-2 Cells

Dietary trimethylamine (TMA) underwent gut microbiota-mediated catabolism and subsequent hepatic oxidation to generate trimethylamine N-oxide (TMAO), a key metabolic factor linked to vascular and colorectal diseases. While the systemic effects of circulating TMAO were heavily investigated, the direct localized cellular interactions of its precursor, TMA, at the intestinal epithelial level required further elucidation. This study characterized extracellular vesicles isolated from Lactobacillus rhamnosus (Lr-EVs) and evaluated their cytoprotective potential in an in vitro human intestinal Caco-2 cell model under TMA-induced stress. Exposure to a high concentration of TMA (20 mM) significantly reduced Caco-2 viability to 78.8%, triggered intracellular reactive oxygen species (ROS) accumulation, and compromised tight junction integrity as observed via the disruption of Zonula Occludens-1 (ZO-1) alignment. Co-treatment with Lr-EVs (100-300 g/mL) counteracted this cellular toxicity, enhancing cell survival up to 172%. Quantitative PCR analysis revealed that Lr-EVs suppressed the transcriptional upregulation of the pro-inflammatory gene IL-1{beta}, restored the expression of the metabolic regulator SIRT1, and stabilized transcript levels of key mitochondrial-encoded electron transport chain genes (ND6, CYTB, CO1, and ATP6). Additionally, Lr-EVs exhibited intrinsic radical scavenging activities in cell-free ABTS and DPPH assays. These preliminary in vitro findings demonstrated that Lr-EVs mitigated TMA-induced cellular injury, oxidative stress, and junctional disruption at the transcriptomic level, supporting further investigation of probiotic-derived EVs as prospective cell-free functional ingredients.

microbiology↗

Metagenomic Insights into the Fecal Microbiome, Resistome, and Mobilome of Beef Cattle in Cow-Calf Operations in Florida, United States

Food-producing animals are a focus of One Health approaches to antimicrobial resistance (AMR) as reservoirs of antimicrobial-resistant bacteria (ARB) and antimicrobial resistance genes (ARGs). We hypothesized that microbial composition, ARGs profiles, and mobile genetic element (MGE) profiles would differ by operation size and animal age group. Fecal samples from 162 cows and calves were combined into 54 composite samples, each comprising three animals of the same age group. Across operation sizes, Bacillota (51.4-64.9%), Bacteroidota (12.0-17.3%), Pseudomonadota (10.3-16.5%), and Actinomycetota (3.3-10.9%) were predominant phyla. Alpha diversity did not differ among operation sizes; however, cows exhibited greater observed richness, Shannon diversity, and Simpson diversity than calves (all P < 0.001). Microbial composition did not differ significantly among operation sizes (PERMANOVA, R{superscript 2} = 0.065, P = 0.609) but differed significantly between cows and calves (R{superscript 2} = 0.200, P < 0.001). Seventy-five ARGs representing 14 resistance classes were identified. Normalized ARG hit rates were higher in small operations (0.444) than in medium (0.278) and large operations (0.222; P = 0.088), whereas calves exhibited a higher estimated marginal mean normalized ARG hit rate than cows (0.383 vs. 0.247 hits/million reads; P < 0.001). Of 1,054 curated ARG hits, 23.9% occurred on predicted plasmid contigs, 0.9% on predicted viral contigs, and 7.1% on contigs containing insertion sequences. Overall findings demonstrate differences in fecal microbiome diversity and ARG abundance between cows and calves and indicate that predicted plasmids are associated with a notable proportion of ARG hits in Florida beef cow-calf operations.

microbiology↗